miR-124 Inducer Compounds With Improved Oral Absorption
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current miR-124 inducers, such as ABX464, suffer from poor physicochemical properties and unsatisfactory oral absorption, necessitating the development of novel compounds with higher potency, improved metabolic stability, and enhanced safety profiles.
Innovation Solution
Development of compounds represented by Formula (1) or their isomers, pharmaceutically acceptable salts, hydrates, or solvates, which are designed to induce miR-124 expression with potent activity and good metabolic stability, including specific structural variations of R, R1, A, X, and Y, and the ability to form heteroaryl or heterocyclyl groups.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If ABX464 is used as an miR-124 inducer, then anti-inflammatory and antiviral effects are achieved, but oral absorption and metabolic stability are poor
Solution Approach 1:
The patent applies parameter changes by systematically modifying the chemical structure of ABX464 through variations in R groups, ring structures, and molecular weight to optimize both oral absorption and metabolic stability while preserving miR-124 induction capability. Multiple compounds with different physicochemical parameters are synthesized and evaluated to identify optimal structures that balance efficacy and pharmacokinetic properties.
2Reliability
If ABX464 is used as an miR-124 inducer, then anti-inflammatory and antiviral effects are achieved, but metabolic stability is poor
Solution Approach 1:
The patent employs parameter changes by modifying molecular weight, lipophilicity, and structural rigidity through various R group substitutions and ring system variations to enhance metabolic stability. The systematic exploration of chemical space identifies compounds with improved half-life and reduced metabolic clearance while maintaining the ability to induce miR-124 expression.
3Quantity of substance
If novel compounds are developed to improve oral absorption and metabolic stability, then pharmacokinetic properties are enhanced, but potency may be reduced
Solution Approach 1:
The patent resolves this contradiction through systematic parameter optimization, where each structural modification is evaluated for its impact on both potency and pharmacokinetic properties. By carefully adjusting molecular weight, lipophilicity, and structural features, the patent identifies compounds that achieve improved oral absorption and metabolic stability without sacrificing miR-124 induction potency.
Data Source
Figure 1
AI summary
The present invention relates to a compound represented by formula (1) and a preparation method therefor, a composition containing the compound represented by formula (1), and/or a pharmaceutically acceptable salt thereof, a preparation method therefor, and a use of the compound as a miR-124 inducer in the preparation of a medication for treating miR-124 mediated diseases.